Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Randomized Trial of Radiotherapy Plus Panitumumab Compared to Chemoradiotherapy With Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck

NCT00547157 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT00547157
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00547157 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Randomized Trial of Radiotherapy Plus Panitumumab Compared to Chemoradiotherapy With Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Lead sponsor
Amgen
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2007
Completion date
March 31, 2012
Enrollment
152 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, head and neck cancer, oncology, squamous cell carcinoma